v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
| Column | Value |
|---|---|
| Trial registration number | NCT05453188 |
|
Full text link
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
|
|
First author
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
|
|
Contact
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
Not reported |
|
Registration date
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
2022-07-12 |
|
Recruitment status
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
Completed |
|
Study design
Last imported at : Aug. 17, 2023, 10:09 a.m. Source : ClinicalTrials.gov |
nonRCT |
|
Allocation
Last imported at : Aug. 17, 2023, 10:09 a.m. Source : ClinicalTrials.gov |
Non-randomized |
|
Design
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
Parallel |
|
Masking
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
Open label |
|
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
|
Study aim
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
Long covid |
|
Inclusion criteria
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
inclusion criteria: persistent symptoms of covid for more than one year. age between 30 and 60 years. complete vaccination schedule (one dose is sufficient, as this was considered by the ministry for patients who have passed the disease). recent basic blood test. |
|
Exclusion criteria
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
presence of comorbidities of musculoskeletal origin that contraindicate the practice of the proposed exercise. presence of uncontrolled cardiac or respiratory disease. presence of incapacitating neurological disease that significantly interferes with the proposed exercise activity severe anaemia or other co-morbidities that significantly interfere with the proposed exercise activity diagnosis or symptoms of dysautonomia presence of high rates of fatigue desaturations during the exercise test that imply a need for oxygen supply for exercise desaturation on exertion during exercise ≥3%. |
|
Number of arms
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
2 |
|
Funding
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
Universidad Francisco de Vitoria |
|
Inclusion age min
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
30 |
|
Inclusion age max
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
60 |
|
Countries
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
Spain |
|
Type of patients
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
Patients recovered from covid |
|
Severity scale
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
N/A |
|
Total sample size
Last imported at : Aug. 17, 2023, 10:09 a.m. Source : ClinicalTrials.gov |
30 |
|
primary outcome
Last imported at : July 20, 2022, noon Source : ClinicalTrials.gov |
36-Item Short Form Survey (SF-36);EuroQoL Quality of Life Scale (EQ5D);Lactic acid concentration;Modified Fatigue Impact Scale (MFIS) |
|
Notes
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
None |
|
Phase
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
Not reported |
|
Arms
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "recovered from covid", "treatment_id": 2558, "treatment_name": "Nordic walking", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "healty", "treatment_id": 2558, "treatment_name": "Nordic walking", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}] |